Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) has earned a consensus rating of “Moderate Buy” from the five ...

Enanta Pharmaceuticals Inc (ENTA) stock saw a decline, ending the day at $5.75 which represents a decrease of $-0.10 or -1.71% from the prior close of $5.85. The stock opened at $6 and touched a low ...

NASDAQ:ENTA opened at $6.01 on Monday. Enanta Pharmaceuticals, Inc. has a 12-month low of $5.70 and a 12-month high of $17.80. The firm has a market cap of $127.38 million, a PE ratio of -1.10 and ...

Technical analysis for Enanta Pharmaceuticals Inc. ENTA including support levels resistance levels and stop losses for ENTA ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Senores Pharmaceuticals Share Price Live Updates: Senores Pharmaceuticals shares made their Dalal Street debut today after high demand for its initial public offering (IPO). Senores ...

Senores Pharmaceuticals Share Price, IPO Listing Live: The company raised Rs 260.63 crore from anchor investors. (Image: Freepik) Senores Pharmaceuticals Share Price, IPO Listing Highlights ...

Wedbush analyst Yun Zhong initiated coverage of Rocket Pharmaceuticals (RCKT) with an Outperform rating and $32 price target Discover the latest stocks recommended by top Wall Street analysts ...